LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

    Wakefield, Lalage M / Hill, Caroline S

    Nature reviews. Cancer

    2013  Volume 13, Issue 5, Page(s) 328–341

    Abstract: Much of the focus on the transforming growth factor-β (TGFβ) superfamily in cancer has revolved around the TGFβ ligands themselves. However, it is now becoming apparent that deregulated signalling by many of the other superfamily members also has crucial ...

    Abstract Much of the focus on the transforming growth factor-β (TGFβ) superfamily in cancer has revolved around the TGFβ ligands themselves. However, it is now becoming apparent that deregulated signalling by many of the other superfamily members also has crucial roles in both the development of tumours and metastasis. Furthermore, these signalling pathways are emerging as plausible therapeutic targets. Their roles in tumorigenesis frequently reflect their function in embryonic development or in adult tissue homeostasis, and their influence extends beyond the tumours themselves, to the tumour microenvironment and more widely to complications of cancer such as cachexia and bone loss.
    MeSH term(s) Animals ; Cell Differentiation ; Cell Proliferation ; Embryonic Development ; Humans ; Molecular Targeted Therapy ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Neoplasms/pathology ; Neoplastic Stem Cells/physiology ; Protein Processing, Post-Translational ; Signal Transduction ; TGF-beta Superfamily Proteins/physiology ; Tumor Microenvironment
    Chemical Substances TGF-beta Superfamily Proteins
    Language English
    Publishing date 2013-04-18
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2062767-1
    ISSN 1474-1768 ; 1474-175X
    ISSN (online) 1474-1768
    ISSN 1474-175X
    DOI 10.1038/nrc3500
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics.

    Chen, Jin-Qiu / Wakefield, Lalage M / Goldstein, David J

    Journal of translational medicine

    2015  Volume 13, Page(s) 182

    Abstract: There is an emerging demand for the use of molecular profiling to facilitate biomarker identification and development, and to stratify patients for more efficient treatment decisions with reduced adverse effects. In the past decade, great strides have ... ...

    Abstract There is an emerging demand for the use of molecular profiling to facilitate biomarker identification and development, and to stratify patients for more efficient treatment decisions with reduced adverse effects. In the past decade, great strides have been made to advance genomic, transcriptomic and proteomic approaches to address these demands. While there has been much progress with these large scale approaches, profiling at the protein level still faces challenges due to limitations in clinical sample size, poor reproducibility, unreliable quantitation, and lack of assay robustness. A novel automated capillary nano-immunoassay (CNIA) technology has been developed. This technology offers precise and accurate measurement of proteins and their post-translational modifications using either charge-based or size-based separation formats. The system not only uses ultralow nanogram levels of protein but also allows multi-analyte analysis using a parallel single-analyte format for increased sensitivity and specificity. The high sensitivity and excellent reproducibility of this technology make it particularly powerful for analysis of clinical samples. Furthermore, the system can distinguish and detect specific protein post-translational modifications that conventional Western blot and other immunoassays cannot easily capture. This review will summarize and evaluate the latest progress to optimize the CNIA system for comprehensive, quantitative protein and signaling event characterization. It will also discuss how the technology has been successfully applied in both discovery research and clinical studies, for signaling pathway dissection, proteomic biomarker assessment, targeted treatment evaluation and quantitative proteomic analysis. Lastly, a comparison of this novel system with other conventional immuno-assay platforms is performed.
    MeSH term(s) Biomarkers/analysis ; Electrophoresis, Capillary/methods ; Humans ; Immunoassay/methods ; Nanotechnology/methods ; Pathology, Molecular/methods ; Proteomics/methods
    Chemical Substances Biomarkers
    Keywords covid19
    Language English
    Publishing date 2015-06-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ISSN 1479-5876
    ISSN (online) 1479-5876
    DOI 10.1186/s12967-015-0537-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.

    Moshkovich, Nellie / Ochoa, Humberto J / Tang, Binwu / Yang, Howard H / Yang, Yuan / Huang, Jing / Lee, Maxwell P / Wakefield, Lalage M

    Cancer research

    2020  Volume 80, Issue 11, Page(s) 2125–2137

    Abstract: Peptidylarginine deiminases (PADI) catalyze posttranslational modification of many target proteins and have been suggested to play a role in carcinogenesis. Citrullination of histones by PADI4 was recently implicated in regulating embryonic stem and ... ...

    Abstract Peptidylarginine deiminases (PADI) catalyze posttranslational modification of many target proteins and have been suggested to play a role in carcinogenesis. Citrullination of histones by PADI4 was recently implicated in regulating embryonic stem and hematopoietic progenitor cells. Here, we investigated a possible role for PADI4 in regulating breast cancer stem cells. PADI4 activity limited the number of cancer stem cells (CSC) in multiple breast cancer models
    MeSH term(s) Animals ; Breast Neoplasms/enzymology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Disease Progression ; Female ; Gene Knockdown Techniques ; Humans ; Isoenzymes ; MCF-7 Cells ; Mice ; Nanog Homeobox Protein/genetics ; Nanog Homeobox Protein/metabolism ; Neoplastic Stem Cells/enzymology ; Neoplastic Stem Cells/pathology ; Octamer Transcription Factor-3/genetics ; Octamer Transcription Factor-3/metabolism ; Protein-Arginine Deiminase Type 4/antagonists & inhibitors ; Protein-Arginine Deiminase Type 4/genetics ; Protein-Arginine Deiminase Type 4/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Transcriptome
    Chemical Substances Isoenzymes ; NANOG protein, human ; Nanog Homeobox Protein ; Octamer Transcription Factor-3 ; POU5F1 protein, human ; Transcription Factors ; PADI4 protein, human (EC 3.5.3.15) ; Protein-Arginine Deiminase Type 4 (EC 3.5.3.15)
    Language English
    Publishing date 2020-04-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-19-3018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide.

    Chen, Xin / Wakefield, Lalage M / Oppenheim, Joost J

    Oncoimmunology

    2014  Volume 3, Page(s) e28247

    Abstract: In a mouse model of breast carcinoma, the combination of cyclophosphamide and transforming growth factor β1,2,3 (TGFβ1,2,3)-targeting antibody achieved superior antineoplastic effects. This novel paradigm of synergistic chemoimmunotherapy promises to ... ...

    Abstract In a mouse model of breast carcinoma, the combination of cyclophosphamide and transforming growth factor β1,2,3 (TGFβ1,2,3)-targeting antibody achieved superior antineoplastic effects. This novel paradigm of synergistic chemoimmunotherapy promises to improve the clinical outcome of cancer patients with micrometastases, and thus deserves further investigation.
    Language English
    Publishing date 2014-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2645309-5
    ISSN 2162-402X ; 2162-4011
    ISSN (online) 2162-402X
    ISSN 2162-4011
    DOI 10.4161/onci.28247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.

    Flanders, Kathleen C / Wakefield, Lalage M

    Journal of mammary gland biology and neoplasia

    2009  Volume 14, Issue 2, Page(s) 131–144

    Abstract: During rodent mammary gland involution there is a dramatic increase in the expression of the transforming growth factor-beta isoform, TGF-beta3. The TGF-betas are multifunctional cytokines which play important roles in wound healing and in carcinogenesis. ...

    Abstract During rodent mammary gland involution there is a dramatic increase in the expression of the transforming growth factor-beta isoform, TGF-beta3. The TGF-betas are multifunctional cytokines which play important roles in wound healing and in carcinogenesis. The responses that are activated in the remodeling of the gland during involution have many similarities with the wound healing process and have been postulated to generate a mammary stroma that provides a microenvironment favoring tumor progression. In this review we will discuss the putative role of TGF-beta during involution, as well as its effects on the mammary microenvironment and possible implications for pregnancy-associated tumorigenesis.
    MeSH term(s) Animals ; Apoptosis/physiology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cicatrix/physiopathology ; Disease Progression ; Female ; Gene Expression Profiling ; Humans ; Inflammation/physiopathology ; Lactation/physiology ; Mammary Glands, Animal/physiology ; Mice ; Parity ; Pregnancy ; Pregnancy Complications, Neoplastic/physiopathology ; Prognosis ; Protein Isoforms/physiology ; RNA, Messenger/biosynthesis ; RNA, Neoplasm/biosynthesis ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/physiology ; Transforming Growth Factor beta3/physiology ; Treatment Outcome ; Wound Healing/physiology
    Chemical Substances Protein Isoforms ; RNA, Messenger ; RNA, Neoplasm ; Transforming Growth Factor beta ; Transforming Growth Factor beta3
    Language English
    Publishing date 2009-04-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1327345-0
    ISSN 1573-7039 ; 1083-3021
    ISSN (online) 1573-7039
    ISSN 1083-3021
    DOI 10.1007/s10911-009-9122-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.

    Wakefield, Lalage M / Stuelten, Christina

    Cancer cell

    2007  Volume 12, Issue 4, Page(s) 293–295

    Abstract: TGFbetas are thought to have tumor suppressor activity in many organ systems, but receptor inactivation in mouse models has not previously resulted in increased spontaneous tumorigenesis. A study in this issue of Cancer Cell shows that mice with a ... ...

    Abstract TGFbetas are thought to have tumor suppressor activity in many organ systems, but receptor inactivation in mouse models has not previously resulted in increased spontaneous tumorigenesis. A study in this issue of Cancer Cell shows that mice with a targeted knockout of the type II TGFbeta receptor in stratified epithelia specifically develop spontaneous squamous cell carcinomas in the anogenital region, but not in the skin. Loss of TGFbeta signaling appears to destabilize the epithelium such that homeostasis fails in the face of persistent proliferative challenge, a normal feature of the anogenital site, and latent invasive and migratory phenotypes are unmasked.
    MeSH term(s) Animals ; Anus Neoplasms/metabolism ; Anus Neoplasms/pathology ; Apoptosis ; Carcinoma, Squamous Cell/enzymology ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/pathology ; Cell Movement ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Cell Transformation, Neoplastic/pathology ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Extracellular Matrix/metabolism ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Homeostasis ; Humans ; Integrins/metabolism ; Keratin-14/genetics ; Keratinocytes/metabolism ; Keratinocytes/pathology ; Mice ; Mice, Knockout ; Mutation ; Neoplasm Invasiveness ; Papilloma/metabolism ; Papilloma/pathology ; Promoter Regions, Genetic ; Protein-Serine-Threonine Kinases/deficiency ; Protein-Serine-Threonine Kinases/genetics ; Protein-Serine-Threonine Kinases/metabolism ; Receptors, Transforming Growth Factor beta/deficiency ; Receptors, Transforming Growth Factor beta/genetics ; Receptors, Transforming Growth Factor beta/metabolism ; Signal Transduction ; Skin/metabolism ; Skin/pathology ; Skin/physiopathology ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology ; Time Factors ; Transforming Growth Factor beta/metabolism ; Urogenital Neoplasms/metabolism ; Urogenital Neoplasms/pathology ; Wound Healing ; ras Proteins/genetics ; ras Proteins/metabolism ; src-Family Kinases/metabolism
    Chemical Substances Integrins ; KRT14 protein, human ; Keratin-14 ; Receptors, Transforming Growth Factor beta ; Transforming Growth Factor beta ; Focal Adhesion Protein-Tyrosine Kinases (EC 2.7.10.2) ; src-Family Kinases (EC 2.7.10.2) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; transforming growth factor-beta type II receptor (EC 2.7.11.30) ; ras Proteins (EC 3.6.5.2)
    Language English
    Publishing date 2007-10
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 2078448-X
    ISSN 1878-3686 ; 1535-6108
    ISSN (online) 1878-3686
    ISSN 1535-6108
    DOI 10.1016/j.ccr.2007.10.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Transforming Growth Factor-βs and Mammary Gland Involution; Functional Roles and Implications for Cancer Progression

    Flanders, Kathleen C / Wakefield, Lalage M

    Journal of mammary gland biology and neoplasia. 2009 June, v. 14, no. 2

    2009  

    Abstract: During rodent mammary gland involution there is a dramatic increase in the expression of the transforming growth factor-β isoform, TGF-β3. The TGF-βs are multifunctional cytokines which play important roles in wound healing and in carcinogenesis. The ... ...

    Abstract During rodent mammary gland involution there is a dramatic increase in the expression of the transforming growth factor-β isoform, TGF-β3. The TGF-βs are multifunctional cytokines which play important roles in wound healing and in carcinogenesis. The responses that are activated in the remodeling of the gland during involution have many similarities with the wound healing process and have been postulated to generate a mammary stroma that provides a microenvironment favoring tumor progression. In this review we will discuss the putative role of TGF-β during involution, as well as its effects on the mammary microenvironment and possible implications for pregnancy-associated tumorigenesis.
    Language English
    Dates of publication 2009-06
    Size p. 131-144.
    Publisher Springer US
    Publishing place Boston
    Document type Article
    ZDB-ID 1327345-0
    ISSN 1083-3021
    ISSN 1083-3021
    DOI 10.1007/s10911-009-9122-z
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta.

    Park, Hae-Young / Wakefield, Lalage M / Mamura, Mizuko

    Immune network

    2009  Volume 9, Issue 4, Page(s) 122–126

    Abstract: Transforming growth factor-beta (TGF-beta) is a highly pleiotropic cytokine playing pivotal roles in immune regulation. TGF-beta facilitates tumor cell survival and metastasis by targeting multiple cellular components. Focusing on its immunosuppressive ... ...

    Abstract Transforming growth factor-beta (TGF-beta) is a highly pleiotropic cytokine playing pivotal roles in immune regulation. TGF-beta facilitates tumor cell survival and metastasis by targeting multiple cellular components. Focusing on its immunosuppressive functions, TGF-beta antagonists have been employed for cancer treatment to enhance tumor immunity. TGF-beta antagonists exert anti-tumor effects through #1 activating effector cells such as NK cells and cytotoxic CD8(+) T cells (CTLs), #2 inhibiting regulatory/suppressor cell populations, #3 making tumor cells visible to immune cells, #4 inhibiting the production of tumor growth factors. This review focuses on the effect of TGF-beta on T cells, which are differentiated into effector T cells or newly identified tumor-supporting T cells.
    Language English
    Publishing date 2009-08-31
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2536191-0
    ISSN 2092-6685 ; 2092-6685
    ISSN (online) 2092-6685
    ISSN 2092-6685
    DOI 10.4110/in.2009.9.4.122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium.

    Flanders, Kathleen C / Yang, Yu-An / Herrmann, Michelle / Chen, JinQiu / Mendoza, Nerissa / Mirza, Amer M / Wakefield, Lalage M

    Oncotarget

    2016  Volume 7, Issue 25, Page(s) 38164–38179

    Abstract: Transforming growth factor-βs (TGF-βs) regulate tissue homeostasis, and their expression is perturbed in many diseases. The three isoforms (TGF-β1, -β2, and -β3) have similar bioactivities in vitro but show distinct activities in vivo. Little ... ...

    Abstract Transforming growth factor-βs (TGF-βs) regulate tissue homeostasis, and their expression is perturbed in many diseases. The three isoforms (TGF-β1, -β2, and -β3) have similar bioactivities in vitro but show distinct activities in vivo. Little quantitative information exists for expression of TGF-β isoform proteins in physiology or disease. We developed an optimized method to quantitate protein levels of the three isoforms, using a Luminex® xMAP®-based multianalyte assay following acid-ethanol extraction of tissues. Analysis of multiple tissues and plasma from four strains of adult mice showed that TGF-β1 is the predominant isoform with TGF-β2 being ~10-fold lower. There were no sex-specific differences in isoform expression, but some tissues showed inter-strain variation, particularly for TGF-β2. The only adult tissue expressing appreciable TGF-β3 was the mammary gland, where its levels were comparable to TGF-β1. In situ hybridization showed the luminal epithelium as the major source of all TGF-β isoforms in the normal mammary gland. TGF-β1 protein was 3-8-fold higher in three murine mammary tumor models than in normal mammary gland, while TGF-β3 protein was 2-3-fold lower in tumors than normal tissue, suggesting reciprocal regulation of these isoforms in mammary tumorigenesis.
    MeSH term(s) Animals ; Female ; Humans ; Mammary Neoplasms, Experimental/immunology ; Mammary Neoplasms, Experimental/pathology ; Mice ; Mice, Inbred BALB C ; Protein Isoforms ; Transforming Growth Factor beta/metabolism ; Transforming Growth Factor beta1/metabolism ; Transforming Growth Factor beta3/metabolism
    Chemical Substances Protein Isoforms ; Transforming Growth Factor beta ; Transforming Growth Factor beta1 ; Transforming Growth Factor beta3
    Language English
    Publishing date 2016-05-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.9416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The two faces of transforming growth factor beta in carcinogenesis.

    Roberts, Anita B / Wakefield, Lalage M

    Proceedings of the National Academy of Sciences of the United States of America

    2003  Volume 100, Issue 15, Page(s) 8621–8623

    MeSH term(s) Animals ; Female ; Genes, Tumor Suppressor ; Humans ; Mammary Neoplasms, Experimental/etiology ; Mammary Neoplasms, Experimental/genetics ; Mammary Neoplasms, Experimental/physiopathology ; Mice ; Models, Biological ; Neoplasm Metastasis/genetics ; Neoplasm Metastasis/physiopathology ; Neoplasm Metastasis/therapy ; Neoplasms/etiology ; Neoplasms/genetics ; Neoplasms/physiopathology ; Oncogenes ; Signal Transduction ; Transforming Growth Factor beta/physiology ; Tumor Suppressor Proteins/physiology
    Chemical Substances Transforming Growth Factor beta ; Tumor Suppressor Proteins
    Language English
    Publishing date 2003-07-22
    Publishing country United States
    Document type Comment ; Journal Article ; Review
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1633291100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top